Development and Multicenter Evaluation of the N Latex CDT Direct Immunonephelometric Assay for Serum Carbohydrate-Deficient Transferrin

Autor: Heinz Jürgen Roth, Catherine Born, Anders Helander, Joris R. Delanghe, Wolfgang K. Gentzer, François Schellenberg, J. Maurits Pekelharing, Jos P.M. Wielders, Eray Yagmur, Harald Althaus
Rok vydání: 2007
Předmět:
Zdroj: Clinical Chemistry. 53:1115-1121
ISSN: 1530-8561
0009-9147
DOI: 10.1373/clinchem.2006.084459
Popis: Background: Carbohydrate-deficient transferrin (CDT) is a promising biomarker of alcohol abuse. We describe the development and multicenter evaluation of N Latex CDT (Dade Behring), an automated, particle-enhanced, homogeneous immunonephelometric assay for directly determining CDT.Methods: N Latex CDT uses a monoclonal antibody that recognizes the structure of transferrin glycoforms lacking 1 or 2 complete N-glycans [i.e., disialo-, monosialo-, and asialotransferrins (CDT glycoforms)] in combination with a simultaneous assay for total transferrin. The Dade Behring BN II™ and BN ProSpec® systems automatically calculate the CDT value as a percentage of total transferrin (%CDT). No preanalytical sample treatment is used.Results: Total imprecision values for serum pools containing 1.8%–8.7% CDT were 3.4%–10.4% (mean, 6.8%). The mean (SD) %CDT for 561 serum samples from healthy control individuals was 1.76% (0.27%; range, 1.01%–2.85%). No marked sex or age differences were noted. The 97.5th percentile was at 2.35%. Transferrin genetic variants did not interfere with measurements. High transferrin concentrations did not falsely increase %CDT values, but increased %CDT values were noted for some samples with transferrin concentrations Conclusion: N Latex CDT is the first direct immunoassay for quantifying %CDT in serum. The specificity of N Latex CDT for identifying alcohol abuse may be higher than for immunoassays that use column separation, because transferrin genetic variants do not interfere with measurements.
Databáze: OpenAIRE